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In vitro antimicrobial susceptibility of ceftriax-
one/sulbactam/ethylenediaminetetraacetic acid
and comparison to other
beta-lactam/beta-lactamase inhibitors,
carbapenems and colistin against gram
negative bacteria
S. Jain ∗, A. Gupta, V. Khare
Max Hospital, Shalimar Bagh, Delhi, India
Background: Drug resistance against Gram Negative Bacte-
ria (GNB) is increasing. Incidence of ESBL producing bacteria is
around 70-80%. Carbapenem resistance has also been reached
40-90% for the GNB. We are also obtaining Colistin resistant
isolates. Resistance against Beta-lactam (BL)/beta-lactamase
inhibitor (BLI) combinations is already very high. No new antibi-
otic or antibiotic group is in pipeline at least for the next
5-10 years. With this background the objective of this study
is to compare in vitro susceptibility of new BL/BLI combina-
tion Ceftriaxone/Sulbactam/Ethylenediaminetetraacetic Acid
(CSE) to Piperacillin/Tazobactam, Cefoperazone/Sulbactam,
Cefepime/Tazobactam, Meropenem, Imipenem and Colistin.
Methods & Materials: Study was conducted on all clin-
ical samples received from all critical care units between
January 2014 and June 2015. Identiﬁcation and susceptibil-
ity was done by Vitek 2 compact system. Susceptibilities
of Ceftriaxone/Sulbactam/Ethylenediaminetetraacetic Acid and
Cefepime/Tazobactam were done by disc diffusion method on
the bases of CLSI guidelines. Escherichia coli, Klebsiella sp., Pseu-
domonas sp. and Acinetobacter sp. isolates were included in the
study.
Results: Escherichia coli (324, 25%) was the most common bac-
teria isolated followed by Klebsiella sp. (309, 24%), Pseudomonas
sp. (217, 17%) and Acinetobacter sp. (214, 17%) from all clinical
samples. % Susceptibilities were as given in table below.
Organism Number
of isolates
CSE Cefepime/
Tazobactam
Piperacillin/
Tazobactam
Cefoperazone/
Sulbactam
Meropenem Imipenem Colistin
Escherichia coli 324 67.4 77.3 46.5 57.9 73.1 72.7 99.5
Klebsiella sp. 309 28.3 37.6 18.6 26.2 32 32 70.9
Pseudomonas sp. 217 43.1 64.1 40.6 46.9 52.4 50.3 93.8
Acinetobacter sp. 214 24.3 13.9 11.3 23.6 12.5 11.8 95.8
Conclusion: Colistin was the most sensitive antimicrobial for
all GNB. Carbapenem resistance was around 27% - 89%. CSE
susceptibility was better than Piperacillin/Tazobactam and Cefop-
erazone/Sulbactam and comparable toMeropenem and Imipenem.
Although the number of isolates included in this study were less in
number, a larger study needs to be conducted. This is an in vitro
susceptibility data hence study has to be conducted for clinical
efﬁciency of CSE.
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Antimicrobial susceptibility and serotype
distribution of invasive and non-invasive
streptococcus pneumoniae isolates and
comparison from healthy carriers
S. Jain1,∗, B.K. Das1, S. Tyagi1, A. Kapil 1, R.
Chaudhry1, S. Sood1, S.K. Kabra1, D. Nair2
1 All India Institute of Medical Sciences, New Delhi,
Delhi, India
2 Vardmann Mahavir Medical college & Safdarjung
Hospital, New Delhi, India
Background: Streptococcus pneumoniae is amajor cause ofmor-
bidity and mortality in developing countries. S. pneumoniae as a
commensal in nasopharynxplays a signiﬁcant role in infection. This
study was undertaken to determine the antimicrobial susceptibil-
ity pattern and serotype distribution of S. pneumoniae isolates from
invasive & non invasive infection and correlate it with isolates from
commensal nasopharyngeal ﬂora to ascertain their role in infection
in our population.
Methods & Materials: S. pneumoniae isolates from Blood/CSF
and respiratory secretions (sputum, BAL and nasopharyngeal
swab/throat swab) were analyzed to determine serotype and
antimicrobial susceptibility pattern. Serotyping was performed
by the quellung reaction. Antimicrobial susceptibility testing
was determined using disk diffusion method against the fol-
lowing antibiotics: Penicillin (1g oxacillin), Amoxicillin (1g),
Amox-clav (30g), Vancomycin (30g), Erythromycin (15g),
Tetracycline (30g), Levoﬂoxacin (5g), Oﬂoxacin (5g), Gati-
ﬂoxacin (5g), Trimethoprim-sulfamethoxazole (1.25/23.75g),
Chloramphenicol (30g), Linezolid (30g) as per CLSI guidelines.
Minimum inhibitory concentration was determined using E-test
for penicillin. S. pneumoniae ATCC 49619 was used as a control.
Results: A total of 31 isolates were collected including 11 from
sputum, 15 from throat swab/nasopharyngeal swab, 1 from BAL
and 4 from CSF. Invasive isolates belonged to serotypes 14, 3 & 15B.
Themost frequent serotypes among isolates obtained from sputum
were 7, 22 & 35. Isolates from nasopharyngeal swab/throat swab
belonged to serotypes 6, 19, 1 & 11 out of which serotype 6 was
the most common. Two isolates were non-typable. Out of 31 pneu-
mococcal isolates 3(9.6%), 7 (22.5%) and 28 (90.3%) were resistant
to penicillin, erythromycin and trimethoprim-sulfamethoxazole
respectively. Oxacillin resistant isolates were further tested for
penicillin susceptibility by E-test. All 3 oxacillin resistant isolates
demonstrated intermediate resistance topenicillin. These3 isolates
were non-invasive. All isolates were susceptible to vancomycin,
linezolid & amoxicillin-clavullinic acid. It is difﬁcult to isolate inva-
sive S. pneumoniae from clinical samples therefore non-invasive
isolates fromsputumcanbegoodsurrogate for antibiotic resistance
monitory.
Conclusion: In present study although the number of isolates
are small, increase in the incidence of penicillin resistance is wor-
risome. There is a need to monitor penicillin resistance among
invasive & non-invasive pneumococcal isolates. Our study implies
